Browsing Category
Health
Paratek Pharmaceuticals Announces NUZYRA® (omadacycline) Has Been Added to the CDC Plague Guidelines…
BOSTON, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening…
ReWalk Robotics to Report Second Quarter 2021 Financial Results on August 9, 2021
MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Aug. 04, 2021 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its second quarter 2021 financial…
Tarsus Pharmaceuticals, Inc. Reports Second Quarter 2021 Financial Results and Provides Business and…
Announced positive results of the Saturn-1 pivotal trial evaluating TP-03 for the treatment of Demodex blepharitis; results presented at the 2021 American Society of Cataract and Refractive Surgery (ASCRS) conference Initiated…
Sky Century Investment, Inc. Announces Its Plans to Expand Its CBD Products Assortment
Las Vegas, NV, Aug. 04, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sky Century Investment, Inc. (OTC Markets: SKYI), a Nevada registered company, committed to selling the highest quality CBD products using only pharmaceutical grade…
Passage Bio Mourns the Sudden Passing of Chairman of the Board Tadataka Yamada, M.D.
PHILADELPHIA, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system disorders, acknowledges today with…
First Patient Dosed in CUPID Study of Telix’s Targeted Alpha Therapy Candidate for Prostate Cancer
MELBOURNE, Australia, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) announces today that the first patient has been dosed in its ‘CUPID’ first-in-human Phase I study of the Company’s…
Imugene and Celularity Announce an Exclusive Strategic Partnership to Develop a Novel Oncolytic…
Collaboration will initially explore the therapeutic potential of a combination of Imugene’s CF33-CD19 oncolytic virus (onCARlytics) and Celularity’s CD19 targeting chimeric antigen receptor (CAR) placental-derived investigational T-cell…
T2 Biosystems to Participate in the Canaccord Genuity 41st Annual Growth Conference
LEXINGTON, Mass., Aug. 04, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced plans to participate in the upcoming Canaccord Genuity 41st Annual Growth…
Alpha Healthcare Acquisition Corp. Sets August 24, 2021, for Special Shareholder Meeting to Vote on…
Special shareholder meeting to approve, among other items, the proposed business combination with Humacyte, Inc. to be held August 24, 2021, at 10:00 a.m. EDTShareholders as of the close of business on July 21, 2021, should vote their AHAC…
Ascend to Bring Lowell Smokes to Illinois on August 5
CHICAGO, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Lowell Farms Inc. (CSE:LOWL; OTCQX:LOWLF), a California-born innovator in cannabis cultivation and maker of the legendary brand Lowell Smokes and multi-state, vertically-integrated cannabis…
TOMI Environmental Introduces The SteraPak – The Most Portable SteraMist System
FREDERICK, Md., Aug. 04, 2021 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT)…